Omnicare Inc. (OCR)
-NYSE 47.50 
0.24(0.51%) 19 Jun 04:00 SGT|After Hours
:
47.50 0.00 (0.00%) 19 Jun 04:11 SGT
| Prev Close: | 47.26 |
|---|
| Open: | 47.56 |
|---|
| Bid: | 45.32 x 200 |
|---|
| Ask: | 48.45 x 200 |
|---|
| 1y Target Est: | 46.57 |
|---|
| Beta: | 1.56 |
|---|
| Next Earnings Date: | 22-Jul-13 |
|---|
| Day's Range: | 47.38 - 47.81 |
|---|
| 52wk Range: | 29.24 - 47.95 |
|---|
| Volume: | 623,525 |
|---|
| Avg Vol (3m): | 983,272 |
|---|
| Market Cap: | 4.98B |
|---|
| P/E (ttm): | 27.14 |
|---|
| EPS (ttm): | 1.75 |
|---|
| Div & Yield: | 0.56 (1.20%) |
|---|
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Omnicare, Walgreen's should not see margin falloff, says UBStheflyonthewall.com(Mon, 17 Jun)
- Omnicare's Trust Preferred Income Equity Redeemable Securities About To Put More Money In Your Pocketat Forbes(Tue, 11 Jun)
- Omnicare to Participate in the Goldman Sachs 34th Annual Global Healthcare ConferenceThomson Reuters ONE(Fri, 7 Jun)
- Omnicare Reaches New 52-Week High (OCR)at TheStreet(Thu, 6 Jun)
- Omnicare cold be a takeout candidate, says Credit Suissetheflyonthewall.com(Thu, 6 Jun)
- Omnicare: Long-Term Buy For Growth Investorsat Seeking Alpha(Wed, 5 Jun)
- Omnicare, Inc. Shareholders Seeking to Restore Value in Company Stock Should Contact Deans & Lyons Law FirmPR Newswire(Fri, 31 May)
- Omnicare Unit Partners Drug BusterZacks(Fri, 31 May)
- Hospice Pharmacia Announces Partnership with Drug Buster for Aiding Hospices in Disposal of Unused MedicationThomson Reuters ONE(Thu, 30 May)
- Omnicare Stock Hits New 52-Week High (OCR)at TheStreet(Tue, 28 May)
Key Statistics
| Forward P/E (1 yr): | 12.40 |
|---|
| P/S (ttm): | 0.81 |
|---|
| Ex-Dividend Date: | 30-May-13 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 3.55 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.86 |
|---|
| Mean Recommendation*: | 2.3 |
|---|
| PEG Ratio (5 yr expected): | 0.88 |
|---|
Business Summary
Omnicare, Inc. operates as a healthcare services company that specializes in the management of pharmaceutical care in the United States and Canada. The company operates in two segments, Long-Term Care Group and Specialty Care Group.
View More